Angelus:
it's not a flame war to challenge facts.
sorry but the AFR is a pretty solid source and they make it clear that there is no failure on MSB's part to explain the lower SP. So it's not my personal opinion, it's fact.
Do you have any facts to explain why the SP is not a reflection of broader market sentiment on biotechs?
Either there is a factual basis for the drop or it's market sentiment. What else is there?
Manipulation you're ruling out?
any thoughts on the bizarre low volume?, page-15
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
-0.010(1.08%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 94.0¢ | 91.5¢ | $1.609M | 1.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 131951 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 22000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |